Background: Balloon dilation is safe and effective for the treatment of radiation-induced esophageal stricture (RIES), with favorable short-term and mid-term outcomes; however, few reports of long-term outcomes exist. Few studies have evaluated factors associated with recurrence after balloon dilation. Purpose: To evaluate the long-term outcome of balloon dilation in patients with RIES and to identify factors associated with stricture recurrence. Material and Methods: The medical records of 62 consecutive patients who had undergone fluoroscopic balloon dilation for RIES at our institution between December 1998 and June 2016 were reviewed. Results: One hundred and twenty balloon dilation sessions were performed in 62 patients (mean ¼ 1.9 sessions per patient). Clinical success was achieved in 53 (86%) patients after single (n ¼ 37) or multiple (n ¼ 16) dilation sessions. Complications occurred in 27% of the dilation sessions. The primary patency rates at one, two, three, and five years were 60%, 56%, 52%, and 52%, respectively. Secondary patency rates at one, two, three, and five years were 87%, 85%, 85%, and 80%, respectively. Multivariate logistic regression analysis identified an interval from radiation therapy (RT) to stricture of 6 months (hazard ratio [HR] ¼ 0.205; P < 0.001), strictures located at the cervical esophagus (HR ¼ 5.846; P < 0.001), and stricture length of 2 cm (HR ¼ 2.923; P ¼ 0.006) as significant predictors of recurrence. Conclusion: Despite the high incidence of ruptures and recurrences, fluoroscopic balloon dilation is valuable as an initial therapeutic option for patients with RIES.
Introduction
Radiation therapy (RT), either alone or combined with surgery and/or chemotherapy is an integral part of the oncological treatment for a wide range of malignancies in the neck and thorax (1) (2) (3) . However, exposure of the surrounding normal tissues to radiation and the toxicity it induces can lead to a number of acute and late complications (3, 4) . Radiation-induced esophageal stricture (RIES) is one of the most common late complications of RT. This condition is believed to be due to chronic inflammation and fibrosis, and usually occurs 3-8 months (median ¼ 6 months) after completion of RT (5, 6) . The estimated risk of developing RIES is less than 2% in patients treated with a dose of 50 Gy or less, but rises to 15% in those treated with a dose of 60 Gy (3) .
RIES has a great impact on the patient's quality of life and has been managed by surgical resection, bougienage, and balloon dilation (5) (6) (7) (8) (9) (10) . Endoscopic and/ or fluoroscopic balloon dilation is increasingly used as a minimally invasive alternative to corrective surgery for the treatment of RIES. This treatment modality is not only associated with lower morbidity and mortality rates compared with corrective surgery, but is also associated with more rapid improvement of symptoms and shorter hospital stays (11) (12) (13) . Several studies have shown that balloon dilation is safe and effective for the treatment of RIES, with favorable short-and mid-term outcomes; however, few reports of longterm outcomes exist (9, 14) . In addition, few studies have evaluated factors associated with recurrence after balloon dilation (15, 16) . The purpose of our present study was to evaluate the long-term outcomes of balloon dilation in patients with RIES and to identify factors associated with its recurrence.
Material and Methods

Patient population
This retrospective study was approved by our institutional review board and the requirement to obtain written informed consent was waived. We retrospectively reviewed the prospectively collected records of patients who underwent fluoroscopic balloon dilation between December 1998 and June 2016. The inclusion criterion was patients who underwent fluoroscopic balloon dilation for the treatment of RIES. The diagnosis of RIES was based on history, clinical signs and symptoms, radiographic and endoscopic examinations, and, when necessary, biopsy. Patients with mild symptoms where the stricture could be passed with an adult endoscope, patients with distal gastrointestinal obstructions, and patients with documented malignancy at the time of the diagnosis of RIES were excluded.
A total of 62 patients (45 men, 17 women; mean age ¼ 60 years; age range ¼ 40-81 years) were included in the present study. All patients underwent radiation therapy for either lung cancer (n ¼ 28), esophageal cancer (n ¼ 21), head and neck cancer (n ¼ 8), or breast cancer (n ¼ 5). The radiation dose was in the range of 39.6-71.4 Gy (mean ¼ 57.8 Gy) over 3.4-13.7 weeks (mean ¼ 6.2 weeks). The interval between completion of RT and diagnosis of RIES was in the range of 2.7-9.3 months (median ¼ 4.7 months). The length of the stricture was in the range of 1-6 cm (mean ¼ 2.1 cm). The demographics and clinical characteristics of the patients are summarized in Table 1 .
Balloon dilation procedure
The technique used for fluoroscopic balloon dilation has been described in detail elsewhere (13, 14) . Briefly, a 0.035-inch stiff-angled guide wire (Radiofocus M; Terumo, Tokyo, Japan) was inserted through the mouth and negotiated across the stricture into the stomach. A balloon catheter (MAXI LD; Cordis, Johnson & Johnson, Miami, FL, USA), with a diameter of 14-20 mm and a length of 4-6 cm, was passed over the guide wire. The size of the balloon was selected by the operator according to the normal adjacent lumen and severity of the stricture. The balloon was gradually inflated with diluted water-soluble contrast medium (Fig. 1) . 
Follow-up
All patients were evaluated at one, three, and six months after balloon dilation and every six months thereafter or whenever clinically indicated on an outpatient basis until death. Patients who could not return for evaluation were followed-up by telephone. Esophagography was performed at one month after balloon dilation to evaluate the status of the stricture and the patients' swallowing capacity. A further esophagography or endoscopy was performed when clinically indicated.
Data collection and definition
The patients' medical records were reviewed to collect data on demographics, clinical characteristics, technical success, procedural details, clinical success, recurrence, complication, patency, and survival. Technical success was defined as the successful passage of a balloon catheter through the stricture and total disappearance of the waist of the stricture after balloon dilation. Clinical success was defined as improvement of symptoms after single or multiple dilation sessions without recurrence until the end of the follow-up period or death.
Recurrence was defined as the return of all symptoms after a technically and clinically successful dilation session. Rupture was categorized into three types according to the classification suggested by Kang et al. (14) . Primary patency was defined as the interval between initial balloon dilation and the first episode of recurrence. Secondary patency was defined as the interval between initial dilation session and the latest episode of recurrence, regardless of the number of dilation sessions. Survival was defined as the interval between initial dilation session and death.
Statistical analysis
Univariate and multivariate Cox proportional hazards regression analyses with a counting process approach was performed to identify independent predictors of recurrence. A cutoff P value of <0.1 in the univariate analysis was used to select variables for inclusion in the multivariate model. Robust variance estimation was used to account for within-subject correlation caused by the clustering of recurrences within patients. Multivariate analysis was restricted to the first three recurrence events to avoid strata with very small sample sizes. Cox proportional hazards assumptions were tested using Schoenfeld's residual analysis. A twosided P value of <0.05 was considered to indicate statistical significance. All statistical analyses were performed using the SPSS software (version 19.0; SPSS, Chicago, IL, USA) and R software (version 0.99.48; R Foundation for Statistical Computing, Vienna, Austria).
Results
Technical success and procedural details
A total of 120 balloon dilation sessions were performed in 62 patients (mean ¼ 1.9 sessions per patient; 
Complications
The complications found in this study were esophageal ruptures, which occurred in 25% (30/120) of the dilation sessions in 21 (34%) patients. Ruptures after balloon dilation was located at the cervical (n ¼ 3), upper (n ¼ 3), and middle esophagus (n ¼ 15). The ruptures were of type 1 (n ¼ 21) and type 2 (n ¼ 9) ruptures. These patients were managed conservatively by means of fasting, administration of antibiotics, and parenteral alimentation. ERF occurred in two (3%) patients immediately after balloon dilation. These patients were treated by temporary SEMS placement to seal off the fistula. There was no mortality directly related to balloon dilation. Data are the number of patients, with percentages in parentheses, unless otherwise specified. 
Temporary SEMS placement
Four (7%) patients underwent placement of temporary SEMS due to frequent recurrences (n ¼ 2) or ERF (n ¼ 2). Two patients with frequent recurrences underwent SEMS placement as a result of the short-term recurrence within four weeks after balloon dilation. The stents were removed 48 and 52 days after stent placement, respectively. After removal of the stents, the strictures became widely patent with no recurrence until the patient's death. In one of two patients with ERF, the SEMS completely occluded the fistula with no further aspiration symptoms. However, the other patient had persistent symptoms of aspiration because of incomplete ERF closure, although stent placement was technically successful. This patient underwent percutaneous gastrostomy.
Survival and patency
During the follow-up period, 47 (76%) patients died mostly because of cancer recurrence and the five-year survival rate was only 24% (15 of 62 patients). Median survival was 14.7 months (95% CI ¼ 10.2-19.3) (Fig. 3 ). Primary patency rates at one, three, and six months and one, two, three, and five years were 91%, 80%, 70%, 60%, 56%, 52%, and 52%, respectively. Secondary patency rates at one, three, and six months and one, two, three, and five years were 100%, 98%, 94%, 87%, 85%, 85%, and 80%, respectively. Primary and secondary patency curves are shown in Fig. 4a .
Predictors for recurrence
Univariate analysis identified an association of male sex (P ¼ 0.085), interval from RT to stricture of 6 months (P < 0.001), site of stricture (P ¼ 0.030), stricture length of 2 cm (P ¼ 0.035), and esophageal rupture after the dilation (P ¼ 0.040) with recurrence. Multivariate logistic regression analysis identified interval from RT to stricture of 6 months (hazard ratio [HR] ¼ 0.205; 95% CI ¼ 0.081-0.521; P < 0.001), strictures located at the cervical esophagus (HR ¼ 5.846; 95% CI ¼ 2.844-12.015; P < 0.001), and stricture length of 2 cm (HR ¼ 2.923; 95% CI ¼ 1.361-6.280; P ¼ 0.006) as significant predictors of recurrence (Fig. 4) . There was no evidence of violations for proportional hazards assumptions. The results of univariate and multivariate analysis of predictors for recurrence are shown in Table 3 .
Discussion
In this study, the long-term outcome of balloon dilation for RIES demonstrated excellent curability and adequate palliation of dysphagia by balloon dilation just after one or two sessions in 49 patients (79% of the study population). Balloon dilation of RIES is relatively simple, safe, and easy. Three prognostic factors for recurrence after balloon dilation were demonstrated by the Cox proportional hazards regression analysis; these were stricture located at the cervical esophagus (HR ¼ 2.7, P ¼ 0.047), stricture longer than 2 cm (HR ¼ 3.0, P ¼ 0.028), and time to diagnosis of stricture after RT (HR ¼ 0.948, P < 0.001). On the other hand, total dose and duration of RT did not influence recurrence.
The multivariate analysis showed that time to diagnosis of stricture after RT is the most important factor affecting recurrence after balloon dilation. RIES are diagnosed after 6-8 months (median ¼ 6 months), with the earliest diagnosis made at four months from RT (5). In our study, the median time to diagnosis of stricture after RT was 4.7 months (range ¼ 2.7-9.3 months). Balloon dilation is significantly ineffective in the treatment of early-phase RIES because the healing process of esophageal mucosa injured from radiation is presumably at an active but incomplete state. In cases of corrosive esophageal strictures, most patients with early chronic stage stricture (three weeks to six months) also experience frequent recurrences after balloon dilation (13, 17) . Tuna et al. (15) reported that time to onset of esophageal stricture is the highest risk factor for recurrence after endoscopic bougie dilation. Therefore, it seems that early-phase RIES has a higher recurrence rate after fluoroscopic balloon dilation.
The cervical esophagus is more fragile and radiosensitive than the middle and lower esophagus (18, 19) and is more likely to be associated with impaired swallowing function. In our study, a statistically significant correlation was found between location of the stricture at the cervical esophagus and recurrence. A total of 28 balloon dilation sessions in 11 patients whose strictures were located at the cervical esophagus were performed. During the procedure, five (46%) of these patients developed vocal cord palsy (n ¼ 4) and ERF (n ¼ 1) resulting in clinical failure. Hu et al. (15) reported that strictures at the upper esophagus are more refractory than those at the lower esophagus. RIES at the cervical esophagus were relatively more difficult to manage in comparison with strictures at the middle and lower esophagus. Thus, intense follow-up may be required after balloon dilation in cases of strictures located at the cervical esophagus.
A long stricture length correlates significantly with the need for multiple dilation procedures in order to maintain symptomatic relief (20) . According to previous studies, factors associated with a poor response to balloon dilation of benign esophageal strictures were stricture length more than 8 cm and a small pre-dilation luminal diameter (20, 21) . In the present study, stricture length more than 2 cm was significantly associated with recurrence after balloon dilation compared with that less than 2 cm (focal stricture) in the multivariate model (P ¼ 0.006). The mean number of balloon dilations in patients with focal stricture was also less than that in patients with strictures longer than 2 cm. Previous studies reported that strictures shorter than 1.2 cm showed better responses to balloon dilation than did long strictures and that the number of repeat dilations was correlated with the length of the stricture in patients with benign esophageal anastomotic strictures (22, 23) .
The most serious complication of esophageal dilation is rupture, which usually occurs at the site of the stricture after balloon dilation. Rupture rates have been reported to be in the range of 12-60% depending on the cause of the esophageal strictures (10, (13) (14) (15) (16) (17) 24) . Fan et al. (24) reported that relatively high rupture rate was found with corrosive stricture (37%) and RIES (33%). In the current study, the esophageal rupture occurred in 21 of 62 patients (34%). Although the rupture rate was very high, there were no serious cases requiring surgery in our study. The majority of ruptures were of type 1 (n ¼ 14) and type 2 (n ¼ 7) (21/23, 91 %) and were successfully managed conservatively. Only two (9%) of the patients were treated with a fully-covered SEMS to seal off ERFs caused by the balloon dilation.
Placement of SEMSs has been proposed as a therapeutic option for the treatment of refractory benign esophageal strictures as well as for patients with malignant esophageal strictures with or without ERFs (25) (26) (27) . In particular, anastomotic strictures and strictures caused by RT or corrosive injury are highly resistant to balloon dilation, because those are generally very tight or eccentric (25, 28) . According to the study by Fuccio et. (29) , despite a high level of heterogeneity between studies, the clinical success rate of stent placement in refractory benign esophageal strictures was 41%. However, in our study, clinical success rate of third balloon dilation was only 20%. Two of our study patients had a relatively diffuse stricture refractory to balloon dilations (five and 15 balloon dilation sessions, respectively). We temporarily placed SEMSs for 48 and 52 days, respectively. After removal of the stent, the stricture became widely patent and the patients did not report any dysphagia symptoms. Therefore, temporary stent placement can be an alternative treatment for patients with RIESs refractory to balloon dilation, especially when the second session of balloon dilation fails.
The limitations of our study include its retrospective and non-randomized design and its performance at a single medical center. These factors could introduce some bias and decrease the study's statistical strength. However, to the best of our knowledge, our study analyzed the largest series of RIES treated with balloon dilation under fluoroscopic guidance. In addition, referral bias may have also occurred, due to the heterogeneity of the underlying malignancies, which show markedly diverse responses to radiation therapy. Furthermore, most patients developed cancer recurrence after balloon dilation resulting from relatively less survival rate compared with other benign esophageal strictures.
In conclusion, despite the high incidence of ruptures and recurrences, fluoroscopic balloon dilation is valuable as an initial therapeutic option for patients with RIES. Strictures located at the cervical esophagus, strictures developing early after RT, and stricture length of more than 2 cm were associated with recurrence after balloon dilation.
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